Nike stock has dropped to its lowest level since September 2024, continuing a decline from $178 in 2021 to $40, as analysts anticipate further weakness ahead of its quarterly results on Tuesday. The company's turnaround strategy, aimed at returning to growth through a sport-first identity, increased innovation, inventory improvements, and rebuilding partnerships, has yet to yield significant returns. Analysts project a 2.19% drop in quarterly revenue to $10.85 billion and a 0.08% decline in annual revenue to $46.27 billion.

Analysts Lower Price Targets

Several analysts have reduced their price targets for Nike, reflecting concerns about the company's business challenges. Stifel Nicolaus lowered its target from $56 to $50, while Deutsche Bank’s Krisztina Katai cut from $51 to $43. Oppenheimer’s Brian Nagel and BTIG’s Robert Drbul reduced their targets to $60 and $55, respectively. The consensus is that Nike's recovery is taking longer than expected.

Valuation Concerns and Competitive Pressures

An Evercore analyst warned that Nike remains overvalued despite the sell-off, trading at a forward price-to-earnings ratio of 27, higher than the consumer discretionary average of 17. This valuation exceeds that of growth-focused companies like Nvidia and Micron. Nike faces rising competition, tariffs on imported goods from Asia, and higher costs due to elevated energy prices.

Technical Indicators Signal Further Downside

The daily chart shows a bearish breakout, with the stock falling below the crucial support level of $41.95, invalidating an island reversal pattern formed after a gap on April 1 following Q3 earnings. A head and shoulders pattern suggests further downside, potentially to $35.

Nike Inc. shares are in focus as the company announced a leadership transition and prepares for its fiscal fourth-quarter earnings report next week. The sportswear giant named David M. Denton as Executive Vice President and CFO, effective August 17, succeeding Matthew Friend. This change comes as the stock tests key support levels and analysts adjust their ratings ahead of the financial disclosure.

CFO Transition

Denton joins Nike from Pfizer, where he has served as CFO since May 2022. He brings over 30 years of finance and operating leadership experience, including previous CFO roles at Lowe’s and CVS Health. Matthew Friend will step down on August 17 and remain with the company through September 4 to support the transition. Friend is scheduled to participate in Nike’s fourth quarter fiscal 2026 earnings call on June 30 as planned. CEO Elliott Hill praised Denton as a proven public-company CFO capable of helping consumer brands operate with discipline.

Analyst Consensus & Recent Actions

The stock currently holds a Hold rating with an average price target of $52.94. Recent analyst activity reflects mixed sentiment:

Earnings & Key Metrics

Nike is expected to report earnings per share of 12 cents and revenue of $10.85 billion for the upcoming quarter. In the prior quarter, the company reported earnings per share of 35 cents, beating the consensus estimate of 28 cents, and revenue of $11.28 billion, which exceeded the consensus estimate of $11.23 billion.

Investors are advised to monitor same-store sales growth and e-commerce trends, which are critical for Nike’s recovery strategy. Inventory levels will also be under scrutiny, as significant increases could signal overproduction and further margin strain amidst current demand challenges.

Market Reaction

At the time of publication, Nike shares were trading 0.76% lower at $40.59.